Records containing: Pulmonary Hypertension
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2009-07-29Exercise-induced Pulmonary Hypertension in Patients With Sickle-cell Anemia: an Echocardiographic Study.
-
CLINICAL_TRIALS study record update · 2009-04-16A Phase II, Randomized, Double-Blind, Dose-Controlled, Dose-Ranging, Multicenter Study of BSF 208075 Evaluating Exercise Capacity in Patients With Moderate to Severe Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2009-04-06Right Ventricular Hypertrophy and Pulmonary Hypertension: A Correlation Analysis Between Tc-99m Tetrofosmin SPECT Adn Echocardiography
-
CLINICAL_TRIALS study record update · 2008-05-29A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Short-Term Efficacy and Safety of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
-
CLINICAL_TRIALS study record update · 2008-03-17Use of the Endothelin-1 Antagonist Bosentan in Patients With Established Pulmonary Hypertension and Fibrotic Lung Disease. - A Randomised, Placebo-Controlled, Double-Blinded Study.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2008-02-21PHIRST-1: Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Phosphodiesterase Type 5 (PDE5) Inhibitor Tadalafil in the Treatment in Patients With Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2007-11-09A Phase 3, Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Sitaxsentan Sodium (Thelin™) Treatment With an Open-Label Bosentan Arm in Patients With Pulmonary Arterial Hypertension (PAH)
-
CLINICAL_TRIALS study record update · 2007-08-30An Open-Label, Dose-Determination Safety, Tolerability, and Activity Study of Inhaled NX1011 in Patients With Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2007-08-23Losartan Decreases Pulmonary Artery Pressure and Improves Exercise Capacity in Patients With Pulmonary Hypertension
-
CLINICAL_TRIALS study record update · 2007-04-24ClinicalTrials.gov study NCT00464932
-
CLINICAL_TRIALS study record update · 2007-04-18Effect of Bosentan on Exercise Capacity at High Altitude
-
CLINICAL_TRIALS study record update · 2007-02-23Inhaled Iloprost in Pulmonary Hypertension Secondary to Pulmonary Fibrosis